Companion Animal Postoperative Pain Management Therapeutics Market to Grow with a CAGR of 8.89% through 2030
Growing
focus on animal welfare and a shift towards preventive healthcare for pets, is
expected to drive the Global Companion Animal Postoperative Pain Management
Therapeutics Market growth in the forecast period, 2026-2030
According
to TechSci Research report, “Companion Animal Postoperative Pain Management
Therapeutics Market – Global Industry Size, Share, Trends, Competition
Forecast & Opportunities, 2030F”, the Global Companion Animal
Postoperative Pain Management Therapeutics Market stood at USD
196.21 Million in
2024 and is expected to reach USD 327.53 Million by 2030 with a CAGR of 8.89% during
the forecast period. The Global Companion Animal Postoperative Pain Management
Therapeutics Market is expanding because of increased awareness surrounding the
importance of managing postoperative pain in pets. With the rising number of
pets undergoing surgeries, owners are becoming more concerned with ensuring
that their pets experience minimal discomfort during recovery. Advances in
veterinary medicine, including the development of more effective pain relief
options, are fueling this growth. Moreover, the growing demand for faster
recovery times and improved post-surgical outcomes is driving the adoption of
pain management therapies. As veterinary practices evolve, they increasingly
incorporate pain management as a standard part of their postoperative care
protocols, contributing to the market's positive trajectory.
Several
factors are propelling the market, including a shift in pet care practices
toward comprehensive health management. This shift is driven by the rising
trend of pet humanization, where owners treat their pets with the same level of
care and attention, they would a family member. The veterinary industry is also
adopting more sophisticated treatments, such as customized analgesic therapies
and pain relief regimens tailored to specific surgeries or animal species. The
combination of better veterinary infrastructure, more educated pet owners, and
new product offerings is fueling the market's expansion. As more advanced pain
management drugs and techniques become available, pet owners are increasingly
willing to invest in the health and comfort of their pets.
Growth
opportunities within the market are significant, particularly in emerging
markets where the adoption of modern veterinary practices is on the rise. With
increasing disposable income and a greater willingness to spend on pet care,
there is a strong opportunity for pain management therapies to reach a broader
audience. Additionally, continued innovation in drug development, such as the
introduction of long-lasting injectable painkillers and non-invasive therapies,
holds the potential to transform the market. Expanding the availability of
these treatments to rural areas and offering affordable, effective solutions
will further accelerate growth. The evolving landscape of veterinary care and
the growing number of pet owners seeking better pain management solutions
create a promising environment for the future of this market.
Browse
over XX market data Figures spread through XX Pages and an in-depth TOC on
"Global Companion Animal Postoperative Pain Management Therapeutics Market”
The
Global Companion Animal Postoperative Pain Management Therapeutics Market is
segmented into animal, product, route of administration, regional distribution,
and company.
Based
on the Product, NSAIDs emerged as the fastest growing segment in the Global Companion
Animal Postoperative Pain Management Therapeutics Market during the forecast
period. This is due to their proven efficacy, widespread
use, and growing acceptance among veterinarians and pet owners. NSAIDs are
highly effective in managing inflammation and pain, making them a preferred
choice for postoperative recovery in companion animals. These drugs target
cyclooxygenase (COX) enzymes, which play a key role in pain and inflammation,
thereby facilitating quicker healing and improved mobility in pets following
surgical procedures. The rapid growth is further driven by the availability of
veterinary-specific NSAID formulations designed to cater to the unique
metabolic and physiological needs of companion animals. Products with
extended-release properties and flavored formulations have significantly
improved compliance, as they are easier for pet owners to administer. The
increasing focus on animal welfare and pain management has also led to a rise
in the prescription of NSAIDs for postoperative care. The ongoing innovation in NSAID delivery
mechanisms, such as transdermal patches and chewable tablets, ensures both
effectiveness and convenience. Growing awareness campaigns about the importance
of pain management in pets and regulatory approvals of newer NSAID formulations
have further propelled their adoption, driving robust segment growth.
Based on the Region, Asia-Pacific
emerged as the fastest growing region in the Global Companion Animal Postoperative Pain Management
Therapeutics Market during the forecast period. This is due
to rapid economic growth, increasing pet ownership, and rising awareness of
animal health. As disposable incomes in countries like China, India, Japan, and
South Korea rise, more families are adopting pets, leading to higher demand for
veterinary services, including postoperative care for companion animals. In
addition, the region has seen significant improvements in the veterinary
healthcare infrastructure, with more veterinary clinics and specialized animal
hospitals providing advanced treatment options for pets. Growing awareness
among pet owners about the importance of pain management following surgeries
has also contributed to the market's expansion. Moreover, the Asia-Pacific
region is witnessing an increase in the availability of veterinary
therapeutics, including NSAIDs and opioids, due to favorable regulatory
environments and the entry of international players in the market. The ongoing
development of affordable and effective pain management products tailored to
local needs has further accelerated market growth.
Major companies operating in Global Companion
Animal Postoperative Pain Management Therapeutics Market are:
- Zoetis Inc.
- Merck & Co., Inc.
- Elanco Animal Health Inc.
- Ceva Santé Animale S.A.
- Boehringer Ingelheim International GmbH
- Norbrook Laboratories
- Dechra Pharmaceuticals PLC
- Chanelle Pharma
- Bimeda Holdings Limited
- VETOQUINOL S.A.
Download Free Sample Report
Customers
can also request for 10% free customization on this report
“The
Global Companion Animal Postoperative Pain Management Therapeutics Market is
expanding due to the increasing integration of telemedicine and remote
monitoring in veterinary care. As pet owners seek more convenient ways to
manage their pets' health, telemedicine platforms are being increasingly
utilized to provide postoperative care, including pain management. These
digital platforms enable veterinarians to monitor recovery remotely, adjust
treatment plans in real-time, and offer guidance to pet owners, ensuring
continuous pain management and a faster recovery process for companion animals.
This shift towards technology-driven veterinary services is enhancing the
accessibility and efficiency of postoperative pain management, further
propelling market growth.,”
said Mr. Karan Chechi, Research Director of TechSci Research, a research-based
management consulting firm.
“Companion Animal Postoperative Pain Management
Therapeutics Market - Global Industry Size, Share, Trends, Opportunity, and
Forecast, Segmented By Animal (Dogs, Cats, Horses, Others), By Product (NSAIDs,
Anesthetics, Opioids, Others), By Route of Administration (Oral, Injectable),
By Region and Competition, 2020-2030F”, has evaluated the future growth potential of Global
Companion Animal Postoperative Pain Management Therapeutics Market and provides
statistics & information on market size, structure and future market
growth. The report intends to provide cutting-edge market intelligence and help
decision makers take sound investment decisions. Besides, the report also
identifies and analyzes the emerging trends along with essential drivers,
challenges, and opportunities in Global Companion Animal Postoperative Pain
Management Therapeutics Market.
Contact
TechSci Research LLC
420 Lexington Avenue, Suite 300,
New York, United States- 10170
Tel: +1-332-258-6602
Email: sales@techsciresearch.com
Website: www.techsciresearch.com